A study in the latest issue of the Clinical Gastroenterology & Hepatology evaluates the effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure.
The latest European Journal of Gastroenterology & Hepatology evaluated host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin.
The presence of anti-endomysial antibodies and the level of anti-tissue transglutaminases can be used to diagnose adult coeliac disease without duodenal biopsy, reports November's Alimentary Pharmacology & Therapeutics.
A study in the most recent issue of Clinical Gastroenterology & Hepatology characterized regional variations in fees charged by gastroenterologists in New york.
Postdischarge occurrences after colorectal surgery happen early and are associated with dramatically increased rates of readmission, reports this month's issue of the Diseases of the Colon & Rectum.
Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases. reports November's issue of Clinical Gastroenterology & Hepatology
A study in the latest issue of the Alimentary Pharmacology & Therapeutics evaluates the performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease.
A study in November's issue of the Clinical Gastroenterology & Hepatology identifies factors associated with readmissions and outcomes of patients hospitalized for IBD.
The latest issue of the Alimentary Pharmacology & Therapeutics examines the association between intestinal barrier dysfunction and central nervous system disorders.
The latest issue of the Journal of Clinical Gastroenterology evaluates the application of hemospray in the luminal tract after upper gastrointestinal bleeding.
A study in this month's Clinical Gastroenterology & Hepatology evaluates the effect of sleep duration on the development of Inflammatory Bowel Diseases.
The latest issue of the Alimentary Pharmacology & Therapeutics evalautes the intersection of mucosal pathophysiology in HIV and inflammatory bowel disease, and its implications for therapy.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .